How we supported our client in advancing biomarker discovery and translational ADC development

March 2, 2026

How we supported our client in advancing biomarker discovery and translational ADC development

read more

How we helped our client anticipate on- and off-target toxicity using patient-derived organoids

February 5, 2026

How we helped our client anticipate on- and off-target toxicity using patient-derived organoids

read more

How we supported our client translate animal toxicity data to human-relevant insights and identify a therapeutic window

February 5, 2026

How we supported our client translate animal toxicity data to human-relevant insights and identify a therapeutic window

read more

How organoid data guided our client in selecting a human-relevant animal model for preclinical toxicology studies

February 5, 2026

How organoid data guided our client in selecting a human-relevant animal model for preclinical toxicology studies

read more

How we enabled our client to bring an oncology clinical candidate to patients within five years

June 26, 2025

How we enabled our client to bring an oncology clinical candidate to patients within five years

read more

Advancing immunotherapy for solid tumors with patient-derived organoids

June 26, 2025

Advancing immunotherapy for solid tumors with patient-derived organoids

read more

How we enabled our client to assess efficacy and selectivity of a bispecific antibody using organoid-based co-cultures

June 26, 2025

How we enabled our client to assess efficacy and selectivity of a bispecific antibody using organoid-based co-cultures

read more

How we modelled human fibroblast-epithelial interactions with organoids to identify IBD targets

June 26, 2025

How we modelled human fibroblast-epithelial interactions with organoids to identify IBD targets

read more

Drug discovery to clinical trials in five years

September 14, 2022

Drug discovery to clinical trials in five years

read more

X

Have any questions?

contact us